This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Magellan (MGLN) Q1 Earnings Top on Lower Medical Utilization
by Zacks Equity Research
Magellan Health's (MGLN) Q1 earnings benefit from higher profit owing to lower utilization of elective procedures.
5 DuPont-Tested Quality Stocks to Buy Amid Coronavirus Fear
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q1 results reflect high expenses and low net income.
Company News for Apr 30, 2020
by Zacks Equity Research
Companies In The News Are: BA, MA, NOC, HUM.
Humana's (HUM) Earnings Beat Estimates in Q1, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) first-quarter results reflect better revenues and growth in Medicare Advantage business.
Humana (HUM) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 11.57% and 3.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.
Will Membership Growth Drive Cigna's (CI) Earnings in Q1?
by Zacks Equity Research
Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.
Healthcare Stock Q1 Earnings Due on Apr 29: ANTM, HUM, AVTR
by Zacks Equity Research
Higher premiums and share buyback might have driven earnings for healthcare stocks in the first quarter of 2020.
Why Humana (HUM) Might Surprise This Earnings Season
by Zacks Equity Research
Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Molina Healthcare's (MOH) Q1 Earnings: What's in Store?
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter results are likely to reflect lower membership, partly offset by better revenues.
What's in the Cards for Anthem's (ANTM) Earnings in Q1?
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings results are likely to reflect higher revenues, backed by its Government and Commercial & Specialty businesses.
Humana (HUM) Gears up for Earnings in Q1: What to Expect
by Zacks Equity Research
Humana's (HUM) Q1 earnings results are likely to reflect growth in revenues, which in turn, are expected to have been driven by its Medicaid and Medicare businesses.
CNC vs. HUM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CNC vs. HUM: Which Stock Is the Better Value Option?
What's in the Cards for Centene's (CNC) Earnings in Q1?
by Zacks Equity Research
Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.
Humana (HUM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Healthcare Stocks Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Earnings results of healthcare sector are likely to reflect solid demand for its products and services from aging population and the growing incidence of COVID-19 illness.
Teladoc Q1 Preliminary Results Gain From Coronavirus-Led Demand
by Zacks Equity Research
The rising adoption of telehealth services prompted by the coronavirus breakdown boosts Teladoc Health's (TDOC) business operations.
Cigna's (CI) New Solution to Boost Its Dental Care Services
by Zacks Equity Research
Cigna (CI) enhances its suite of dental care services with a virtual solution amid the pandemic. This is likely to help contain the virus spread.
Molina Healthcare Gains on Sanders' Exit From Presidential Race
by Zacks Equity Research
Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
What's in the Cards for UnitedHealth's (UNH) Q1 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings results to reflect gain from increase in revenues and the effect of share buyback.
The Zacks Analyst Blog Highlights: Teladoc Health, Anthem, CVS Health and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Teladoc Health, Anthem, CVS Health and Humana
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.